34 related articles for article (PubMed ID: 17088913)
21. Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues.
Keese M; Magdeburg RJ; Herzog T; Hasenberg T; Offterdinger M; Pepperkok R; Sturm JW; Bastiaens PI
J Biol Chem; 2005 Jul; 280(30):27826-31. PubMed ID: 15908435
[TBL] [Abstract][Full Text] [Related]
22. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Chung KY; Shia J; Kemeny NE; Shah M; Schwartz GK; Tse A; Hamilton A; Pan D; Schrag D; Schwartz L; Klimstra DS; Fridman D; Kelsen DP; Saltz LB
J Clin Oncol; 2005 Mar; 23(9):1803-10. PubMed ID: 15677699
[TBL] [Abstract][Full Text] [Related]
23. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D; Humblet Y; Siena S; Khayat D; Bleiberg H; Santoro A; Bets D; Mueser M; Harstrick A; Verslype C; Chau I; Van Cutsem E
N Engl J Med; 2004 Jul; 351(4):337-45. PubMed ID: 15269313
[TBL] [Abstract][Full Text] [Related]
24. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system.
Goldstein NS; Armin M
Cancer; 2001 Sep; 92(5):1331-46. PubMed ID: 11571750
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
[TBL] [Abstract][Full Text] [Related]
28. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor-related peptides and their receptors in human malignancies.
Salomon DS; Brandt R; Ciardiello F; Normanno N
Crit Rev Oncol Hematol; 1995 Jul; 19(3):183-232. PubMed ID: 7612182
[No Abstract] [Full Text] [Related]
30. Epidermal growth factor receptors in colorectal carcinoma.
Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
[TBL] [Abstract][Full Text] [Related]
31. Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.
Piazzi G; Paterini P; Ceccarelli C; Pantaleo MA; Biasco G
Br J Cancer; 2006 Dec; 95(11):1525-8. PubMed ID: 17088913
[TBL] [Abstract][Full Text] [Related]
32. Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?
Dei Tos AP; Ellis I
Eur J Cancer; 2005 Jul; 41(10):1383-92. PubMed ID: 15919198
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
